W. Akpan
Impact in
- Pharmacology top 10%
- Pharmacogenetics and Drug Metabolism
- Antibiotics Pharmacokinetics and Efficacy
-
- Heart Failure Treatment and Management
- Blood Pressure and Hypertension Studies
- Cardiac electrophysiology and arrhythmias
Papers in
-
- Epilepsy research and treatment 3
-
- Pharmacological Effects and Toxicity Studies 3
- Co-authors
- G. Neugebauer (11 shared papers)K. Reiff (4 shared papers)E von Möllendorff (6 shared papers)Peter Neubert (3 shared papers)B. Kaufmann (3 shared papers)Ulrich Martin (2 shared papers)R. Kientsch-Engel (1 shared paper)U. Abshagen (2 shared papers)
- Journals
- Journal of Cardiovascular Pharmacology (2 papers)Clinical Pharmacology & Therapeutics (2 papers)Thrombosis and Haemostasis (1 paper)European Journal of Clinical Pharmacology (1 paper)PubMed (3 papers)
- Partner nations
- United StatesGermanySwitzerland
In The Last Decade
W. Akpan
11 papers receiving 383 citations
Peers
Comparison fields: 5 of 57
- Pharmacology 74
- Cardiology and Cardiovascular Medicine 172
- Analytical Chemistry 77
- Anesthesiology and Pain Medicine 37
- Pharmaceutical Science 21
Countries citing papers authored by W. Akpan
This map shows the geographic impact of W. Akpan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Akpan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Akpan more than expected).
Fields of papers citing papers by W. Akpan
This network shows the impact of papers produced by W. Akpan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Akpan. The network helps show where W. Akpan may publish in the future.
Co-authors
The 13 scholars most cited alongside W. Akpan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Pharmacokinetics and disposition of carvedilol in humans. | 1987 | 115 |
| 2 | 1990 | 98 | |
| 3 | 1987 | 72 | |
| 4 | 1991 | 49 | |
| 5 | 1986 | 29 | |
| 6 | 1991 | 26 | |
| 7 | 1985 | 15 | |
| 8 | 1985 | 7 | |
| 9 | [Interaction of guar with glibenclamide and bezafibrate]. | 1983 | 5 |
| 10 | Performance of a slow-release formulation of isosorbide-5-mononitrate (ISMO retard). | 1989 | 2 |
| 11 | 1987 | 1 |
About W. Akpan
W. Akpan is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health, Anesthesiology and Pain Medicine, Endocrinology, Diabetes and Metabolism and Nephrology, having authored 11 papers that have together received 419 indexed citations. Recurring topics across this work include Epilepsy research and treatment (3 papers), Pharmacological Effects and Toxicity Studies (3 papers), Anesthesia and Sedative Agents (3 papers), Blood properties and coagulation (2 papers), Protease and Inhibitor Mechanisms (2 papers), Blood Coagulation and Thrombosis Mechanisms (2 papers), Pharmacogenetics and Drug Metabolism (1 paper) and Hormonal and reproductive studies (1 paper). The work is most often cited by research in Pharmacology (74 citations), Cardiology and Cardiovascular Medicine (172 citations), Analytical Chemistry (77 citations), Anesthesiology and Pain Medicine (37 citations) and Pharmaceutical Science (21 citations). W. Akpan has collaborated with scholars based in United States, Germany and Switzerland. Frequent co-authors include G. Neugebauer, K. Reiff, E von Möllendorff, Peter Neubert, B. Kaufmann, Ulrich Martin, R. Kientsch-Engel, U. Abshagen, R. Endele and H. Steudel. Their work appears in journals such as Journal of Cardiovascular Pharmacology, Clinical Pharmacology & Therapeutics, Thrombosis and Haemostasis, European Journal of Clinical Pharmacology and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.